Literature DB >> 28207162

Plasma oxidative stress and inflammatory biomarkers are associated with the sizes of the left atrium and pulmonary vein in atrial fibrillation patients.

Jin-Yi Li1, Yan He1, Hong-Hong Ke1, Yu Jin2, Zhi-Yuan Jiang1, Guo-Qiang Zhong1.   

Abstract

BACKGROUND: Oxidative stress and inflammatory processes are responsible for the pathogenesis of AF, but their relationship with the sizes of the LA and PVs in AF patients remains unclear. HYPOTHESIS: Oxidative stress and inflammatory processes are associated with the sizes of the LA and PVs in AF patients.
METHODS: 82 AF patients were compared to 30 control patients by using a case-control study design. Oxidative stress, inflammatory biomarkers and the sizes of the LA and PVs were detected.
RESULTS: (1) Hs-CRP, IL-6, IL-8, TNF-α, MDA and ox-LDL were higher, and SOD was lower in AF patients than in control patients. Hs-CRP, MDA and ox-LDL were higher in permanent AF patients than in paroxysmal and persistent AF patients. (2) CsA of LSPV, RSPV, RIPV, LAA and LAV were statistically higher in AF patients than in control patients. CsA of RSPV, LSPV, LIPV and LAV were higher in permanent AF patients than in paroxysmal and persistent AF patients. (3) In the AF group, hs-CRP and TNF-α were positively correlated with LAV; MDA was positively correlated with CsA of LAA, LSPV and LAV; SOD was passively correlated with CsA of LAA and LAV; ox-LDL was positively correlated with CsA of LAA and LAV. Multivariate logistic regression analysis showed hs-CRP, ox-LDL, RSPV CsA, LIPV CsA and LAV were associated with AF.
CONCLUSIONS: Oxidative stress, inflammatory biomarkers and the sizes of the LA and PVs were significantly increased in AF patients. Hs-CRP, ox-LDL, RSPV CsA, LIPV CsA and LAV were associated with AF persistence.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  atrial fibrillation; inflammation; left atrium; oxidative stress; pulmonary vein

Mesh:

Substances:

Year:  2017        PMID: 28207162      PMCID: PMC6490400          DOI: 10.1002/clc.22633

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  26 in total

1.  ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

Authors:  Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffery L Anderson; Elliott M Antman; Jonathan L Halperin; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano
Journal:  Circulation       Date:  2006-08-15       Impact factor: 29.690

Review 2.  Targeting the vicious inflammation-oxidative stress cycle for the management of heart failure.

Authors:  Neelam Khaper; Sean Bryan; Sanjiv Dhingra; Rohit Singal; Anju Bajaj; Chander M Pathak; Pawan K Singal
Journal:  Antioxid Redox Signal       Date:  2010-10-01       Impact factor: 8.401

3.  C-reactive protein and microalbuminuria are associated with atrial fibrillation.

Authors:  Folkert W Asselbergs; Maarten P van den Berg; Gilles F H Diercks; Wiek H van Gilst; Dirk J van Veldhuisen
Journal:  Int J Cardiol       Date:  2005-01       Impact factor: 4.164

4.  Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: a randomized controlled trial.

Authors:  Takashi Koyama; Hiroshi Tada; Yukio Sekiguchi; Takanori Arimoto; Hiro Yamasaki; Kenji Kuroki; Takeshi Machino; Kazuko Tajiri; Xu Dong Zhu; Miyako Kanemoto-Igarashi; Aiko Sugiyasu; Keisuke Kuga; Yoshio Nakata; Kazutaka Aonuma
Journal:  J Am Coll Cardiol       Date:  2010-10-26       Impact factor: 24.094

5.  Atrial myocardial nox2 containing NADPH oxidase activity contribution to oxidative stress in mitral regurgitation: potential mechanism for atrial remodeling.

Authors:  Jen-Ping Chang; Mien-Cheng Chen; Wen-Hao Liu; Cheng-Hsu Yang; Chien-Jen Chen; Yung-Lung Chen; Kuo-Li Pan; Tzu-Hsien Tsai; Hsueh-Wen Chang
Journal:  Cardiovasc Pathol       Date:  2010-01-18       Impact factor: 2.185

Review 6.  Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification?

Authors:  Roger K Schindhelm; Leonard P van der Zwan; Tom Teerlink; Peter G Scheffer
Journal:  Clin Chem       Date:  2009-06-25       Impact factor: 8.327

7.  Topographic variability of the left atrium and pulmonary veins assessed by 3D-CT predicts the recurrence of atrial fibrillation after catheter ablation.

Authors:  Kunihiko Kiuchi; Akihiro Yoshida; Asumi Takei; Koji Fukuzawa; Mitsuaki Itoh; Kimitake Imamura; Ryudo Fujiwara; Atsushi Suzuki; Tomoyuki Nakanishi; Soichiro Yamashita; Ken-Ichi Hirata; Gaku Kanda; Katsunori Okajima; Akira Shimane; Shinichiro Yamada; Yasuyo Taniguchi; Yoshinori Yasaka; Hiroya Kawai
Journal:  J Arrhythm       Date:  2015-04-25

Review 8.  Inflammation in atrial fibrillation.

Authors:  Yutao Guo; Gregory Y H Lip; Stavros Apostolakis
Journal:  J Am Coll Cardiol       Date:  2012-12-04       Impact factor: 24.094

9.  NOX4-Dependent Hydrogen Peroxide Overproduction in Human Atrial Fibrillation and HL-1 Atrial Cells: Relationship to Hypertension.

Authors:  Jun Zhang; Ji Youn Youn; Antony Y Kim; Rafael J Ramirez; Ling Gao; Doan Ngo; Peng Chen; Jennifer Scovotti; Aman Mahajan; Hua Cai
Journal:  Front Physiol       Date:  2012-06-05       Impact factor: 4.566

10.  Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention.

Authors:  Michael J Davies
Journal:  J Clin Biochem Nutr       Date:  2010-12-28       Impact factor: 3.114

View more
  10 in total

1.  DNA methylation dysregulations in valvular atrial fibrillation.

Authors:  Kangjun Shen; Tao Tu; Zhaoshun Yuan; Jiangfeng Yi; Yangzhao Zhou; Xiaobo Liao; Qiming Liu; Xinmin Zhou
Journal:  Clin Cardiol       Date:  2017-08-28       Impact factor: 2.882

2.  Plasma oxidative stress and inflammatory biomarkers are associated with the sizes of the left atrium and pulmonary vein in atrial fibrillation patients.

Authors:  Jin-Yi Li; Yan He; Hong-Hong Ke; Yu Jin; Zhi-Yuan Jiang; Guo-Qiang Zhong
Journal:  Clin Cardiol       Date:  2017-02-16       Impact factor: 2.882

3.  Association between serum apolipoprotein B and atrial fibrillation: a case-control study.

Authors:  Xia Zhong; Huachen Jiao; Dongsheng Zhao; Jing Teng
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

4.  Blood Plasma Resistin and Atrial Fibrillation in Patients With Cardiovascular Disease.

Authors:  George Samanidis; Anastasios Gkogkos; Stefanos Bousounis; Leonidas Alexopoulos; Despina N Perrea; Konstantinos Perreas
Journal:  Cardiol Res       Date:  2020-08-01

5.  Case-Control Study to Investigate the Association Between Serum Apolipoprotein B/A1 Ratio and Atrial Fibrillation by Sex in 920 Patients from China.

Authors:  Xia Zhong; Huachen Jiao; Dongsheng Zhao; Jing Teng; Mengqi Yang
Journal:  Med Sci Monit       Date:  2022-05-14

6.  A high triglyceride-glucose index is associated with left ventricular dysfunction and atherosclerosis.

Authors:  Tai-Hua Chiu; Hui-Ju Tsai; Hsin-Ying Clair Chiou; Pei-Yu Wu; Jiun-Chi Huang; Szu-Chia Chen
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

7.  The mRNA expression of Il6 and Pdcd1 are predictive and protective factors for doxorubicin‑induced cardiotoxicity.

Authors:  Syu-Ichi Kanno; Akiyoshi Hara
Journal:  Mol Med Rep       Date:  2020-12-10       Impact factor: 2.952

Review 8.  Target Sestrin2 to Rescue the Damaged Organ: Mechanistic Insight into Its Function.

Authors:  Moein Ala; Seyed Parsa Eftekhar
Journal:  Oxid Med Cell Longev       Date:  2021-11-02       Impact factor: 6.543

9.  Retrospective Study from a Single Center to Evaluate the Association Between Sex and Serum Uric Acid Levels in 950 Patients with Atrial Fibrillation.

Authors:  Xia Zhong; Huachen Jiao; Dongsheng Zhao; Jing Teng
Journal:  Med Sci Monit       Date:  2022-05-12

Review 10.  Novel Combined Antioxidant Strategy against Hypertension, Acute Myocardial Infarction and Postoperative Atrial Fibrillation.

Authors:  Ramón Rodrigo; Jaime González-Montero; Camilo G Sotomayor
Journal:  Biomedicines       Date:  2021-05-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.